{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:55:24Z","timestamp":1767851724200,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:00:00Z","timestamp":1273104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00406-010-0116-z","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T11:56:47Z","timestamp":1273060607000},"page":"139-143","source":"Crossref","is-referenced-by-count":93,"title":["Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder"],"prefix":"10.1007","volume":"261","author":[{"given":"Izabela Guimar\u00e3es","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Barreto","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Amaral","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirl\u00e2ndia Pires","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Silva","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mois\u00e9s Evandro","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio L\u00facio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,6]]},"reference":[{"issue":"5","key":"116_CR1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00406-007-0797-0","volume":"258","author":"AB Cunha","year":"2008","unstructured":"Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Gon\u00e7alves CA, Kapczinski F (2008) Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 258(5):300\u2013304","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"116_CR2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","volume":"70","author":"BI Goldstein","year":"2009","unstructured":"Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS (2009) Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 70(8):1078\u20131090","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 2","key":"116_CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00406-008-2012-3","volume":"258","author":"N M\u00fcller","year":"2008","unstructured":"M\u00fcller N, Schwarz MJ (2008) A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Neurosci 258(Suppl 2):97\u2013106","journal-title":"Eur Arch Psychiatry Neurosci"},{"key":"116_CR4","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1001\/jama.293.20.2528","volume":"293","author":"DJ Kupfer","year":"2005","unstructured":"Kupfer DJ (2005) The increasing medical burden in bipolar disorder. JAMA 293:2528\u20132530","journal-title":"JAMA"},{"issue":"6","key":"116_CR5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.pnpbp.2008.01.006","volume":"32","author":"E Brietzke","year":"2008","unstructured":"Brietzke E, Kapczinski F (2008) TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 32(6):1355\u20131361","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"116_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.55782\/ane-2008-1720","volume":"68","author":"I Fingiel","year":"2008","unstructured":"Fingiel I (2008) Pro-inflammatory cytokine TNF-\u03b1 as a neuroprotective agent in the brain. Acta Neurobiol Exp 68:526\u2013534","journal-title":"Acta Neurobiol Exp"},{"key":"116_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1359-6101(96)00026-3","volume":"7","author":"D Aderka","year":"1996","unstructured":"Aderka D (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7:231\u2013240","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"116_CR8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","volume":"12","author":"M Kauer-Sant\u2019anna","year":"2009","unstructured":"Kauer-Sant\u2019anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN (2009) Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 12(4):447\u2013458","journal-title":"Int J Neuropsychopharmacol"},{"key":"116_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","volume":"90","author":"SM O\u2019Brien","year":"2006","unstructured":"O\u2019Brien SM, Scully P, Scott LV, Dinan TG (2006) Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 90:263\u2013267","journal-title":"J Affect Disord"},{"key":"116_CR10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","volume":"9","author":"A Ortiz-Dom\u00ednguez","year":"2007","unstructured":"Ortiz-Dom\u00ednguez A, Hern\u00e1ndez ME, Berlanga C, Guti\u00e9rrez-Mora D, Moreno J, Heinze G, Pav\u00f3n L (2007) Immune variations in bipolar disorder: phasic differences. Bipolar Disord 9:596\u2013602","journal-title":"Bipolar Disord"},{"key":"116_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","volume":"104","author":"YK Kim","year":"2007","unstructured":"Kim YK, Jung HG, Myint AM, Kim H, Park SH (2007) Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 104:91\u201395","journal-title":"J Affect Disord"},{"issue":"5","key":"116_CR12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2265.2007.02963.x","volume":"67","author":"YJ Hung","year":"2007","unstructured":"Hung YJ, Hsieh CH, Chen YJ, Pei D, Kuo SW, Shen DC, Shen WH, Chen YC (2007) Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol (Oxf) 67(5):784\u2013789","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"116_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","volume":"116","author":"E Brietzke","year":"2009","unstructured":"Brietzke E, Stertz L, Fernandes BS, Kauer-Sant\u2019anna M, Mascarenhas M, Escosteguy Vargas A, Chies J\u00c1, Kapczinski F (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116(3):214\u2013217","journal-title":"J Affect Disord"},{"key":"116_CR14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","volume":"157","author":"Z Kronfol","year":"2000","unstructured":"Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683\u2013694","journal-title":"Am J Psychiatry"},{"issue":"6","key":"116_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eurpsy.2008.03.013","volume":"23","author":"H Himmerich","year":"2008","unstructured":"Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S, Gedrich K, Kloiber S, Lucae S, Ising M, Uhr M, Holsboer F, Pollm\u00e4cher T (2008) Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 23(6):421\u2013429","journal-title":"Eur Psychiatry"},{"key":"116_CR16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1440-1819.2008.01918.x","volume":"63","author":"R Grassi-Oliveira","year":"2009","unstructured":"Grassi-Oliveira R, Brietzke E, Pezzi JC, Lopes RP, Teixeira AL, Bauer ME (2009) Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder. Psychiatry Clin Neuroci 63:202\u2013208","journal-title":"Psychiatry Clin Neuroci"},{"issue":"2","key":"116_CR17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000148197","volume":"15","author":"FM Coelho","year":"2008","unstructured":"Coelho FM, Reis HJ, Nicolato R, Romano-Silva MA, Teixeira MM, Bauer ME, Teixeira AL (2008) Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation 15(2):140\u2013144","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"116_CR18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jneuroim.2009.08.001","volume":"216","author":"P Scalzo","year":"2009","unstructured":"Scalzo P, Kummer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-\u03b1 receptor-1 in patients with Parkinson\u2019s disease. J Neuroimmunol 216(1\u20132):122\u2013125","journal-title":"J Neuroimmunol"},{"key":"116_CR19","first-page":"4","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:4\u201357","journal-title":"J Clin Psychiatry"},{"key":"116_CR20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429\u2013435","journal-title":"Br J Psychiatry"},{"key":"116_CR21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1976","unstructured":"Hamilton M (1976) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278\u2013296","journal-title":"Br J Soc Clin Psychol"},{"key":"116_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.1108e31","volume":"69","author":"LJ Byer","year":"2008","unstructured":"Byer LJ (2008) An evidence-based medicine strategy for achieving remission in bipolar disorder. J Clin Psychiatry 69:31\u201337","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"116_CR23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-004-2038-9","volume":"179","author":"H Himmerich","year":"2005","unstructured":"Himmerich H, Koethe D, Schuld A, Yassouridis A, Pollm\u00e4cher T (2005) Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology (Berl) 179(2):447\u2013451","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"116_CR24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-3956(99)00021-7","volume":"33","author":"M Haack","year":"1999","unstructured":"Haack M, Hinze-Selch D, Fenzel T, Kraus T, K\u00fchn M, Schuld A, Pollm\u00e4cher T (1999) Plasma levels of cytokines and soluble cytokines receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 33(5):407\u2013418","journal-title":"J Psychiatr Res"},{"key":"116_CR25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2009.04.027","volume":"120","author":"B Dean","year":"2010","unstructured":"Dean B, Tawadros N, Scarr E, Gibbons AS (2010) Regionally-specific changes in levels of tumor necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. J Affect Disord 120:245\u2013248","journal-title":"J Affect Disord"},{"issue":"12","key":"116_CR26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.ijo.0800773","volume":"22","author":"H Hauner","year":"1998","unstructured":"Hauner H, Bender M, Haastert B, Hube F (1998) Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord 22(12):1239\u20131243","journal-title":"Int J Obes Relat Metab Disord"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-010-0116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-010-0116-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-010-0116-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T12:19:32Z","timestamp":1711455572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-010-0116-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1007\/s00406-010-0116-z","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,6]]}}}